NEWS TIPS & FEATURES

SGO, ASCO Issue New Guidelines for Ovarian Cancer Treatment

A new joint clinical practice guideline from the American Society of Clinical Oncology (ASCO) and the Society of Gynecologic Oncology (SGO) states that neoadjuvant chemotherapy (NACT) is the optimal first-line... [...]


Pancreatic Cancer Cells Find Unique Fuel Sources to Keep from Starving

Pancreatic cancer cells avert starvation in dense tumors by ordering nearby support cells to supply them with an alternative source of nutrition. This is the finding of a study in cancer cells and mice... [...]


Opdivo® Highly Effective for Some Patients with Lymphomas

The immunotherapeutic agent, Opdivo® (nivolumab), appears to provide long-lasting anti-cancer activity among some patients who have received extensive prior therapy for both B- and T-cell lymphomas. These... [...]


Midlife PSA Levels Correlate to Risk of Future Lethal Prostate Cancer

A baseline prostate-specific antigen (PSA) level among men at midlife appears to be highly correlated with the risk of developing lethal prostate cancer within their lifetimes. These results were recently... [...]


T-Cells Can be Directed to Treat a Variety of Ovarian Cancers

With only incremental improvements in ovarian cancer survival over the last 40 years, there is a clear need for new treatment options with long-lasting results. Many researchers have turned toward the... [...]


Hair Transplant after Cancer Treatment

Amy Gibson and Dr. Craig Ziering discuss hair transplant after cancer treatment in this informative video. Have more questions about hair transplant after treatment? Join the conversation in the Cancer... [...]


Considering a Wig for Treatment-related Hair Loss? Start Here

In this informative video, Amy Gibson discusses the differences between wig bases. Have more questions about which wig is right for you? Join the conversation in the Cancer HairCare online support community... [...]


New Tool Helps Men Evaluate Watchful Waiting in Early Stage Prostate Cancer

Over 90 percent of prostate cancers are detected at a curable stage, with men more likely to die of other diseases than from this cancer. Although patients with localized, low-risk prostate cancer have... [...]


Pracinostat Receives Breakthrough Therapy Designation from FDA for Treatment in Combination with Azacitidine of Patients with Newly Diagnosed Acute Myeloid Leukemia

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for the investigational drug Pracinostat in combination with azacitidine for the treatment of elderly patients with... [...]


« More News Tips & Features

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS